Urolithin A

Overview
Urolithin A is a microbial metabolite formed when suitable gut organisms convert ellagitannin-derived ellagic acid. Pomegranate, walnuts and some berries can supply precursors, but the amount of Urolithin A formed varies substantially between people. Within BRAIN it is therefore represented as a downstream metabolite with a precursor-and-conversion pathway, not as an intrinsic constituent of those foods [1,4].
Research on mitophagy and mitochondrial resilience includes preclinical work and direct supplemental Urolithin A exposure. A human trial showed that oral Urolithin A can produce a molecular signature consistent with mitochondrial response, but this does not establish that precursor foods reliably reproduce the tested exposure [1,2]. Disease and cognition claims remain exposure- and model-dependent [3].
Dietary Context
The canonical dietary path is Pomegranate or another ellagitannin source → provides ellagitannins/ellagic acid → microbial conversion → Urolithin A. It is not Pomegranate → contains → Urolithin A. Producer status depends on microbial capacity, substrate exposure and host context.
Direct supplementation bypasses precursor conversion and produces a more controlled Urolithin A exposure [1,2]. That intervention relationship is distinct from dietary precursor exposure and must retain its supplemental context.
Research Spotlights & Evidence Checks
Foods
Recipes
Biological Regulatory Systems
| Biological Regulatory System | Evidence-qualified relationship | Evidence |
|---|---|---|
| Gut-Brain Axis & Enteric Nervous System (BRS5) | BRS5-FM2-PM6 represents microbial polyphenol biotransformation from dietary precursors to downstream metabolites such as Urolithin A | [1,4] |
| Mitochondrial Function & Bioenergetics (BRS4) | Direct Urolithin A exposure has mitophagy and mitochondrial-response evidence; dietary precursor exposure is not assumed equivalent | [1–3] |
| Inflammation & Oxidative Stress (BRS3) | Redox and inflammatory relevance remains model- and exposure-specific rather than a general pomegranate effect | [3] |
References
[1] Singh et al. (2022). Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults. Establishes direct supplemental exposure as distinct from variable microbial production after precursor-food intake.
[2] Andreux et al. (2019). The mitophagy activator Urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Human direct-exposure study supporting qualified mitochondrial-response claims.
[3] Hou et al. (2024). Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions. Preclinical disease-model evidence relevant to mechanism but not equivalent to a human clinical or precursor-food outcome.
[4] Zelicha et al. (2022). The effect of high-polyphenol Mediterranean diet on visceral adiposity: the DIRECT PLUS randomized controlled trial. Whole-diet evidence involving microbiome-derived Urolithin A markers; it does not establish that pomegranate contains Urolithin A or isolate Urolithin A as the cause.